Halozyme Therapeutics, Inc. - Laporan Laba Rugi (TTM)

Halozyme Therapeutics, Inc.
DE ˙ DB ˙ US40637H1095
€ 62.58 ↓ -1.32 (-2.07%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Halozyme Therapeutics, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 200 268 331 412 463 443 472 487 581 660 705 774 781 829 863 873 947 1,015 1,084 1,179
Change (%) 34.09 23.79 24.52 12.25 -4.25 6.37 3.37 19.11 13.69 6.80 9.74 0.91 6.22 4.07 1.20 8.48 7.17 6.79 8.70
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 89 78 89 105 119 117 118 136 173 206 216 252 260 269 247 214 209 238 258 265
Change (%) -12.36 14.54 18.45 13.07 -1.64 0.47 15.59 27.17 19.08 5.10 16.29 3.23 3.44 -7.99 -13.56 -1.99 13.85 8.37 2.66
% of Revenue 44.37 29.00 26.83 25.52 25.71 26.41 24.94 27.89 29.78 31.19 30.70 32.53 33.27 32.41 28.65 24.47 22.11 23.49 23.83 22.51
Gross Operating Profit 111 190 242 307 344 326 354 352 408 454 489 537 536 561 616 660 738 777 826 913
Change (%) 71.15 27.57 26.75 11.96 -5.16 8.49 -0.69 15.99 11.41 7.57 9.89 -0.20 4.61 9.85 7.12 11.87 5.28 6.31 10.59
% of Revenue 55.63 71.00 73.17 74.48 74.29 73.59 75.06 72.11 70.22 68.81 69.30 69.39 68.63 67.59 71.35 75.53 77.89 76.51 76.17 77.49
SG&A 48 46 44 46 47 50 53 98 120 122 145 127 127 149 147 144 150 154 162 167
Change (%) -4.79 -3.44 3.05 3.22 7.12 5.51 85.04 21.68 1.74 19.34 -12.76 0.63 17.08 -1.49 -2.20 4.16 3.10 4.68 3.65
% of Revenue 24.07 17.09 13.33 11.03 10.15 11.35 11.26 20.16 20.59 18.42 20.59 16.37 16.32 17.99 17.03 16.46 15.80 15.20 14.90 14.21
R&D 15 15 15 16 40 40 -4 -8
Change (%) 0.00 0.00 154.66 0.00 86.06
% of Revenue 2.11 1.92 1.91 1.83 4.60 4.24 -0.39 -0.66
OpEx 137 123 133 151 166 167 171 246 331 371 437 446 445 489 481 469 470 464 487 496
Change (%) -9.70 7.87 13.33 10.10 0.84 1.98 43.87 34.78 11.97 18.00 1.89 -0.10 9.86 -1.64 -2.59 0.35 -1.38 4.96 1.88
% of Revenue 68.45 46.09 40.16 36.56 35.86 37.76 36.20 50.39 57.02 56.15 62.05 57.61 57.03 58.99 55.76 53.67 49.65 45.68 44.90 42.08
Operating Income 63 144 198 262 297 276 301 242 250 289 268 328 335 340 382 405 477 551 597 683
Change (%) 129.09 37.40 32.03 13.48 -7.10 9.04 -19.61 3.19 15.98 -7.56 22.57 2.28 1.38 12.27 5.97 17.90 15.61 8.34 14.26
% of Revenue 31.55 53.91 59.84 63.44 64.14 62.24 63.80 49.61 42.98 43.85 37.95 42.39 42.97 41.01 44.24 46.33 50.35 54.32 55.10 57.92
Interest Expense -19 -20 -17 -14 -11 -8 -7 -9 -14 -17 -20 -21 -18 -19 -19 -19 -19 -18 -18 -18
Change (%) 6.84 -16.60 -19.14 -23.55 -28.37 -2.74 18.47 66.42 17.43 16.43 7.04 -14.25 3.59 -0.19 0.16 0.10 -3.62 0.10 -0.72
% of Revenue -9.56 -7.62 -5.13 -3.33 -2.27 -1.70 -1.55 -1.78 -2.49 -2.57 -2.80 -2.73 -2.32 -2.26 -2.17 -2.15 -1.98 -1.78 -1.67 -1.53
Net Income 22 129 163 229 409 403 435 366 211 202 182 234 254 282 319 337 392 444 485 557
Change (%) 499.73 26.34 40.25 78.86 -1.56 8.00 -15.81 -42.32 -4.29 -10.14 28.67 8.64 10.90 13.21 5.80 16.36 13.15 9.29 14.82
% of Revenue 10.79 48.24 49.23 55.45 88.36 90.84 92.23 75.11 36.37 30.62 25.76 30.21 32.52 33.96 36.94 38.62 41.43 43.74 44.76 47.28

Source: Capital IQ

Other Listings
IT:1HALO € 62.66
MX:HALO
US:HALO US$ 74.93
GB:0J2O
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista